{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:37:01Z","timestamp":1777124221559,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science","award":["24K12086"],"award-info":[{"award-number":["24K12086"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29505-1","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T18:23:06Z","timestamp":1763835786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The local anesthetic, lidocaine, suppresses the growth of colon cancer SW480 cells by decreasing the voltage-gated sodium channel subunit Nav1.5"],"prefix":"10.1038","volume":"15","author":[{"given":"Keiko","family":"Haraguchi-Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chigusa","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reika","family":"Kawabata-Iwakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"key":"29505_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fphar.2017.00561","volume":"8","author":"HO Alsaab","year":"2017","unstructured":"Alsaab, H. O. et al. PD-1 and PD-L1 checkpoint signaling Inhibition for cancer immunotherapy: Mechanism, Combinations, and clinical outcome. Front. Pharmacol. 8, 561. https:\/\/doi.org\/10.3389\/fphar.2017.00561 (2017).","journal-title":"Front. Pharmacol."},{"key":"29505_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"Cancer J. Clin."},{"key":"29505_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1006\/geno.1998.5735","volume":"57","author":"NW Plummer","year":"1999","unstructured":"Plummer, N. W. & Meisler, M. H. Evolution and diversity of mammalian sodium channel genes. Genomics 57, 323\u2013331. https:\/\/doi.org\/10.1006\/geno.1998.5735 (1999).","journal-title":"Genomics"},{"key":"29505_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejphar.2018.07.034","volume":"834","author":"YT Lee","year":"2018","unstructured":"Lee, Y. T., Tan, Y. J. & Oon, C. E. Molecular targeted therapy: treating cancer with specificity. Eur. J. Pharmacol. 834, 188\u2013196. https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.034 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"29505_CR5","doi-asserted-by":"publisher","unstructured":"Brackenbury, W. J. & Isom, L. L. Na channel \u03b2 subunits: overachievers of the ion channel family. Front. Pharmacol. 2 https:\/\/doi.org\/10.3389\/fphar.2011.00053 (2011).","DOI":"10.3389\/fphar.2011.00053"},{"key":"29505_CR6","doi-asserted-by":"publisher","unstructured":"Yanagidate, F. & Strichartz, G. R. Local anesthetics. Handb. Exp. Pharmacol. 95\u2013127. https:\/\/doi.org\/10.1007\/978-3-540-33823-9_4 (2007).","DOI":"10.1007\/978-3-540-33823-9_4"},{"key":"29505_CR7","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1113\/jphysiol.2007.130161","volume":"581","author":"MM McNulty","year":"2007","unstructured":"McNulty, M. M. et al. Charge at the Lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels. J. Physiol. 581, 741\u2013755. https:\/\/doi.org\/10.1113\/jphysiol.2007.130161 (2007).","journal-title":"J. Physiol."},{"key":"29505_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bbamem.2003.07.001","volume":"1616","author":"S Roger","year":"2003","unstructured":"Roger, S., Besson, P. & Le Guennec, J. Y. Involvement of a novel fast inward sodium current in the invasion capacity of a breast cancer cell line. Biochim. Biophys. Acta. 1616, 107\u2013111. https:\/\/doi.org\/10.1016\/j.bbamem.2003.07.001 (2003).","journal-title":"Biochim. Biophys. Acta"},{"key":"29505_CR9","doi-asserted-by":"publisher","unstructured":"Lopez-Charcas, O. et al. Voltage-gated sodium channel Na(V)1.5 Controls NHE-1-dependent invasive properties in colon cancer cells. Cancers 15.  https:\/\/doi.org\/10.3390\/cancers15010046 (2022).","DOI":"10.3390\/cancers15010046"},{"key":"29505_CR10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.biocel.2006.12.007","volume":"39","author":"S Roger","year":"2007","unstructured":"Roger, S. et al. Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines. Int. J. Biochem. Cell Biol. 39, 774\u2013786. https:\/\/doi.org\/10.1016\/j.biocel.2006.12.007 (2007).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"29505_CR11","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1158\/1078-0432.Ccr-05-0327","volume":"11","author":"SP Fraser","year":"2005","unstructured":"Fraser, S. P. et al. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin. Cancer Research: Official J. Am. Association Cancer Res. 11, 5381\u20135389. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-05-0327 (2005).","journal-title":"Clin. Cancer Research: Official J. Am. Association Cancer Res."},{"key":"29505_CR12","doi-asserted-by":"publisher","first-page":"121282","DOI":"10.1016\/j.lfs.2022.121282","volume":"313","author":"MA Erdogan","year":"2023","unstructured":"Erdogan, M. A. et al. SCN5A promotes the growth and lung metastasis of triple-negative breast cancer through EF2-kinase signaling. Life Sci. 313, 121282. https:\/\/doi.org\/10.1016\/j.lfs.2022.121282 (2023).","journal-title":"Life Sci."},{"key":"29505_CR13","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1242\/jcs.123901","volume":"126","author":"L Brisson","year":"2013","unstructured":"Brisson, L. et al. NaV1.5 Na\u207a channels allosterically regulate the NHE-1 exchanger and promote the activity of breast cancer cell invadopodia. J. Cell Sci. 126, 4835\u20134842. https:\/\/doi.org\/10.1242\/jcs.123901 (2013).","journal-title":"J. Cell Sci."},{"key":"29505_CR14","doi-asserted-by":"publisher","first-page":"6957","DOI":"10.1158\/0008-5472.Can-10-1169","volume":"70","author":"CD House","year":"2010","unstructured":"House, C. D. et al. Voltage-gated Na\u2009+\u2009channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res. 70, 6957\u20136967. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-1169 (2010).","journal-title":"Cancer Res."},{"issue":"Suppl 1","key":"29505_CR15","doi-asserted-by":"publisher","first-page":"i95","DOI":"10.1093\/bja\/aet467","volume":"113","author":"F Scavonetto","year":"2014","unstructured":"Scavonetto, F. et al. Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort study. Br. J. Anaesth. 113 (Suppl 1), i95\u2013102. https:\/\/doi.org\/10.1093\/bja\/aet467 (2014).","journal-title":"Br. J. Anaesth."},{"key":"29505_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/aln.0000000000000489","volume":"122","author":"TR Call","year":"2015","unstructured":"Call, T. R. et al. Factors associated with improved survival after resection of pancreatic adenocarcinoma: a multivariable model. Anesthesiology 122, 317\u2013324. https:\/\/doi.org\/10.1097\/aln.0000000000000489 (2015).","journal-title":"Anesthesiology"},{"key":"29505_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bja.2020.03.034","volume":"125","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. Association between intraoperative intravenous Lidocaine infusion and survival in patients undergoing pancreatectomy for pancreatic cancer: a retrospective study. Br. J. Anaesth. 125, 141\u2013148. https:\/\/doi.org\/10.1016\/j.bja.2020.03.034 (2020).","journal-title":"Br. J. Anaesth."},{"key":"29505_CR18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/eja.0000000000001559","volume":"39","author":"L Cazenave","year":"2022","unstructured":"Cazenave, L. et al. Intravenous Lidocaine and cancer outcomes after radical cystectomy. Eur. J. Anaesthesiol. 39, 396\u2013399. https:\/\/doi.org\/10.1097\/eja.0000000000001559 (2022).","journal-title":"Eur. J. Anaesthesiol."},{"key":"29505_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/cam4.3621","volume":"10","author":"C Liu","year":"2021","unstructured":"Liu, C. et al. Lidocaine inhibits the metastatic potential of ovarian cancer by blocking Na(V) 1.5-mediated EMT and FAK\/Paxillin signaling pathway. Cancer Med. 10, 337\u2013349. https:\/\/doi.org\/10.1002\/cam4.3621 (2021).","journal-title":"Cancer Med."},{"key":"29505_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/ALN.0b013e3182661977","volume":"117","author":"T Piegeler","year":"2012","unstructured":"Piegeler, T. et al. Antimetastatic potential of amide-linked local anesthetics: Inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel Blockade. Anesthesiology 117, 548\u2013559. https:\/\/doi.org\/10.1097\/ALN.0b013e3182661977 (2012).","journal-title":"Anesthesiology"},{"key":"29505_CR21","doi-asserted-by":"publisher","first-page":"14520","DOI":"10.1038\/s41598-022-18572-3","volume":"12","author":"K Haraguchi-Suzuki","year":"2022","unstructured":"Haraguchi-Suzuki, K. et al. Local anesthetic lidocaine-inducible gene, growth differentiation factor-15 suppresses the growth of cancer cell lines. Sci. Rep. 12, 14520. https:\/\/doi.org\/10.1038\/s41598-022-18572-3 (2022).","journal-title":"Sci. Rep."},{"key":"29505_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10549-006-9281-1","volume":"101","author":"WJ Brackenbury","year":"2007","unstructured":"Brackenbury, W. J., Chioni, A. M., Diss, J. K. & Djamgoz, M. B. The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat. 101, 149\u2013160. https:\/\/doi.org\/10.1007\/s10549-006-9281-1 (2007).","journal-title":"Breast Cancer Res. Treat."},{"key":"29505_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00249-004-0389-0","volume":"33","author":"JK Diss","year":"2004","unstructured":"Diss, J. K., Fraser, S. P. & Djamgoz, M. B. Voltage-gated Na\u2009+\u2009channels: multiplicity of expression, plasticity, functional implications and pathophysiological aspects. Eur. Biophys. Journal: EBJ. 33, 180\u2013193. https:\/\/doi.org\/10.1007\/s00249-004-0389-0 (2004).","journal-title":"Eur. Biophys. Journal: EBJ"},{"key":"29505_CR24","doi-asserted-by":"publisher","unstructured":"Rougier, J. S., Gavillet, B. & Abriel, H. Proteasome inhibitor (MG132) rescues Nav1.5 protein content and the cardiac sodium current in dystrophin-deficient Mdx (5cv) mice. Front. Physiol. 4 https:\/\/doi.org\/10.3389\/fphys.2013.00051 (2013).","DOI":"10.3389\/fphys.2013.00051"},{"key":"29505_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1161\/01.Res.0000136816.05109.89","volume":"95","author":"MX van Bemmelen","year":"2004","unstructured":"van Bemmelen, M. X. et al. Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination. Circul. Res. 95, 284\u2013291. https:\/\/doi.org\/10.1161\/01.Res.0000136816.05109.89 (2004).","journal-title":"Circul. Res."},{"key":"29505_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s0092-8674(03)00755-4","volume":"115","author":"J Bloom","year":"2003","unstructured":"Bloom, J., Amador, V., Bartolini, F., DeMartino, G. & Pagano, M. Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell 115, 71\u201382. https:\/\/doi.org\/10.1016\/s0092-8674(03)00755-4 (2003).","journal-title":"Cell"},{"key":"29505_CR27","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3892\/mmr.2014.2281","volume":"10","author":"Z Xie","year":"2014","unstructured":"Xie, Z. et al. Bafilomycin A1 inhibits autophagy and induces apoptosis in MG63 osteosarcoma cells. Mol. Med. Rep. 10, 1103\u20131107. https:\/\/doi.org\/10.3892\/mmr.2014.2281 (2014).","journal-title":"Mol. Med. Rep."},{"key":"29505_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/0006-3002(57)90343-8","volume":"23","author":"JC Skou","year":"1957","unstructured":"Skou, J. C. The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim. Biophys. Acta. 23, 394\u2013401. https:\/\/doi.org\/10.1016\/0006-3002(57)90343-8 (1957).","journal-title":"Biochim. Biophys. Acta"},{"key":"29505_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/gtc.12983","volume":"27","author":"K Haraguchi-Suzuki","year":"2022","unstructured":"Haraguchi-Suzuki, K. et al. Local anesthetic Lidocaine induces growth suppression of HeLa cells by decreasing and changing the cellular localization of the proliferation marker Ki-67. Genes Cells: Devoted Mol. Cell. Mech. 27, 675\u2013684. https:\/\/doi.org\/10.1111\/gtc.12983 (2022).","journal-title":"Genes Cells: Devoted Mol. Cell. Mech."},{"key":"29505_CR30","doi-asserted-by":"publisher","unstructured":"Zhang, L. et al. Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A. Cell Prolif. 50 https:\/\/doi.org\/10.1111\/cpr.12364 (2017).","DOI":"10.1111\/cpr.12364"},{"key":"29505_CR31","doi-asserted-by":"publisher","first-page":"14229","DOI":"10.1074\/jbc.M109.097253","volume":"285","author":"W Yan","year":"2010","unstructured":"Yan, W. & Chen, X. Characterization of functional domains necessary for mutant p53 gain of function. J. Biol. Chem. 285, 14229\u201314238. https:\/\/doi.org\/10.1074\/jbc.M109.097253 (2010).","journal-title":"J. Biol. Chem."},{"key":"29505_CR32","first-page":"199","volume":"1","author":"J Gerdes","year":"1990","unstructured":"Gerdes, J. Ki-67 and other proliferation markers useful for Immunohistological diagnostic and prognostic evaluations in human malignancies. Sem. Cancer Biol. 1, 199\u2013206 (1990).","journal-title":"Sem. Cancer Biol."},{"key":"29505_CR33","doi-asserted-by":"publisher","unstructured":"Pukkanasut, P. et al. Voltage-Gated sodium channel Na(V)1.7 inhibitors with potent anticancer activities in medullary thyroid cancer cells. Cancers 15 https:\/\/doi.org\/10.3390\/cancers15102806 (2023).","DOI":"10.3390\/cancers15102806"},{"key":"29505_CR34","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1002\/jcp.27399","volume":"234","author":"RM Guzel","year":"2019","unstructured":"Guzel, R. M., Ogmen, K., Ilieva, K. M., Fraser, S. P. & Djamgoz, M. B. A. Colorectal cancer invasiveness in vitro: predominant contribution of neonatal Nav1.5 under normoxia and hypoxia. J. Cell. Physiol. 234, 6582\u20136593. https:\/\/doi.org\/10.1002\/jcp.27399 (2019).","journal-title":"J. Cell. Physiol."},{"key":"29505_CR35","doi-asserted-by":"publisher","first-page":"100587","DOI":"10.1016\/j.mcpro.2023.100587","volume":"22","author":"G Arad","year":"2023","unstructured":"Arad, G. & Geiger, T. Functional impact of Protein-RNA variation in clinical cancer analyses. Mol. Cell. Proteomics: MCP. 22, 100587. https:\/\/doi.org\/10.1016\/j.mcpro.2023.100587 (2023).","journal-title":"Mol. Cell. Proteomics: MCP"},{"key":"29505_CR36","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature13438","volume":"513","author":"B Zhang","year":"2014","unstructured":"Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382\u2013387. https:\/\/doi.org\/10.1038\/nature13438 (2014).","journal-title":"Nature"},{"key":"29505_CR37","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.1038\/s41598-017-04652-2","volume":"7","author":"U Bahrudin","year":"2017","unstructured":"Bahrudin, U. et al. Inhibitory effects of local anesthetics on the proteasome and their biological actions. Sci. Rep. 7, 5079. https:\/\/doi.org\/10.1038\/s41598-017-04652-2 (2017).","journal-title":"Sci. Rep."},{"key":"29505_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","volume":"19","author":"I Dikic","year":"2018","unstructured":"Dikic, I. & Elazar, Z. Mechanism and medical implications of mammalian autophagy. Nat. Rev. Mol. Cell Biol. 19, 349\u2013364. https:\/\/doi.org\/10.1038\/s41580-018-0003-4 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"29505_CR39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3892\/ijo.2013.2214","volume":"44","author":"C Dulong","year":"2014","unstructured":"Dulong, C. et al. The small GTPase RhoA regulates the expression and function of the sodium channel Nav1.5 in breast cancer cells. Int. J. Oncol. 44, 539\u2013547. https:\/\/doi.org\/10.3892\/ijo.2013.2214 (2014).","journal-title":"Int. J. Oncol."},{"key":"29505_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-3-031-08356-3_7","volume":"1385","author":"M Kaller","year":"2022","unstructured":"Kaller, M., H\u00fcnten, S., Siemens, H. & Hermeking, H. Analysis of the p53\/microRNA network in cancer. Adv. Exp. Med. Biol. 1385, 187\u2013228. https:\/\/doi.org\/10.1007\/978-3-031-08356-3_7 (2022).","journal-title":"Adv. Exp. Med. Biol."},{"key":"29505_CR41","doi-asserted-by":"publisher","first-page":"681223","DOI":"10.3389\/fphar.2021.681223","volume":"12","author":"D Sun","year":"2021","unstructured":"Sun, D., Li, Y. C. & Zhang, X. Y. Lidocaine promoted ferroptosis by targeting miR-382-5p \/SLC7A11 axis in ovarian and breast cancer. Front. Pharmacol. 12, 681223. https:\/\/doi.org\/10.3389\/fphar.2021.681223 (2021).","journal-title":"Front. Pharmacol."},{"key":"29505_CR42","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.prp.2018.09.012","volume":"214","author":"X Qu","year":"2018","unstructured":"Qu, X. et al. Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR. Pathol. Res. Pract. 214, 1974\u20131979. https:\/\/doi.org\/10.1016\/j.prp.2018.09.012 (2018).","journal-title":"Pathol. Res. Pract."},{"key":"29505_CR43","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","volume":"42","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Su, Z., Tavana, O. & Gu, W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer cell. 42, 946\u2013967. https:\/\/doi.org\/10.1016\/j.ccell.2024.04.009 (2024).","journal-title":"Cancer cell."},{"key":"29505_CR44","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3892\/mmr.2015.3370","volume":"12","author":"W Ji","year":"2015","unstructured":"Ji, W. et al. Role of p53\u03b2 in the Inhibition of proliferation of gastric cancer cells expressing wild-type or mutated p53. Mol. Med. Rep. 12, 691\u2013695. https:\/\/doi.org\/10.3892\/mmr.2015.3370 (2015).","journal-title":"Mol. Med. Rep."},{"key":"29505_CR45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/pros.23711","volume":"79","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo. Prostate 79, 62\u201372. https:\/\/doi.org\/10.1002\/pros.23711 (2019).","journal-title":"Prostate"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29505-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29505-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29505-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T12:49:30Z","timestamp":1777121370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29505-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["29505"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29505-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"9 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45018"}}